Investments And Joint Ventures

12 Months Ended

Jun. 30, 2014

Equity Method Investments and Joint Ventures [Abstract]

Investments And Joint Ventures

INVESTMENTS AND JOINT VENTURES

Equity method investments

At June 30, 2014, the Company owned 48.7% of Hain Pure Protein. This investment is accounted for under the equity method of accounting. The carrying value of our investment of $30,742 is included on the Consolidated Balance Sheet in “Investments and joint ventures.” During fiscal 2014 and 2013, HPP repaid $6,038 and $4,116, respectively of our previously provided advances. As of June 30, 2014, there were no outstanding borrowings.

At June 30, 2014, the Company also owned 50.0% of a joint venture, Hutchison Hain Organic Holdings Limited (“HHO”), with Chi-Med, a majority owned subsidiary of Hutchison Whampoa Limited. HHO markets and distributes certain of the Company’s brands in Hong Kong, China and other markets. Voting control of the joint venture is shared 50/50 between the Company and Chi-Med, although, in the event of a deadlock, Chi-Med has the ability to cast the deciding vote. The carrying value of our investment and advances to HHO of $455 are included on the Consolidated Balance Sheet in “Investments and joint ventures.” During the fiscal year ended June 30, 2014, HHO repaid $2,250 of advances we previously made, which amount is reflected in the carrying value of our total investment as of June 30, 2014. The investment is being accounted for under the equity method of accounting.

Available-For-Sale Securities

The Company has a less than 1% equity ownership interest in Yeo Hiap Seng Limited (“YHS”), a Singapore based natural food and beverage company listed on the Singapore Exchange, which is accounted for as an available-for-sale security. The Company sold 2,299,000 of its YHS shares during fiscal year ended June 30, 2014 which resulted in a pre-tax gain of $1,511 on the sales. The remaining shares held at June 30, 2014 totaled 3,072,738. The fair value of these shares held was $5,314 (cost basis of $3,831) at June 30, 2014 and $11,237 (cost basis of $6,696) at June 30, 2013 and is included in “Investments and joint ventures,” with the related unrealized gain or loss, net of tax, included in “Accumulated other comprehensive income” in the Consolidated Balance Sheets.